Oxbridge Re Holdings Earnings Calls
| Release date | May 11, 2026 |
| EPS estimate | -$0.0300 |
| EPS actual | - |
| Revenue estimate | 700K |
| Revenue actual | 623K |
| Revenue Surprise | -11.00% |
| Release date | Mar 30, 2026 |
| EPS estimate | -$0.0200 |
| EPS actual | $0.0200 |
| EPS Surprise | 200.00% |
| Revenue estimate | 700K |
| Revenue actual | 576K |
| Revenue Surprise | -17.71% |
| Release date | Nov 06, 2025 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.0200 |
| EPS Surprise | -100.00% |
| Revenue estimate | 742K |
| Revenue actual | 645K |
| Revenue Surprise | -13.07% |
| Release date | Aug 14, 2025 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.250 |
| EPS Surprise | -2,400.00% |
| Revenue estimate | 742K |
| Revenue actual | 664K |
| Revenue Surprise | -10.51% |
Last 4 Quarters for Oxbridge Re Holdings
Below you can see how OXBR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 14, 2025 |
| Price on release | $1.69 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.250 |
| EPS surprise | -2,400.00% |
| Date | Price |
|---|---|
| Aug 08, 2025 | $1.79 |
| Aug 11, 2025 | $1.70 |
| Aug 12, 2025 | $1.64 |
| Aug 13, 2025 | $1.73 |
| Aug 14, 2025 | $1.69 |
| Aug 15, 2025 | $1.66 |
| Aug 18, 2025 | $1.71 |
| Aug 19, 2025 | $1.66 |
| Aug 20, 2025 | $1.60 |
| 4 days before | -5.38% |
| 4 days after | -5.33% |
| On release day | -1.78% |
| Change in period | -10.41% |
| Release date | Nov 06, 2025 |
| Price on release | $1.33 |
| EPS estimate | -$0.0100 |
| EPS actual | -$0.0200 |
| EPS surprise | -100.00% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $1.52 |
| Nov 03, 2025 | $1.54 |
| Nov 04, 2025 | $1.47 |
| Nov 05, 2025 | $1.41 |
| Nov 06, 2025 | $1.33 |
| Nov 07, 2025 | $1.32 |
| Nov 10, 2025 | $1.31 |
| Nov 11, 2025 | $1.41 |
| Nov 12, 2025 | $1.34 |
| 4 days before | -12.50% |
| 4 days after | 0.752% |
| On release day | -0.752% |
| Change in period | -11.84% |
| Release date | Mar 30, 2026 |
| Price on release | $0.87 |
| EPS estimate | -$0.0200 |
| EPS actual | $0.0200 |
| EPS surprise | 200.00% |
| Date | Price |
|---|---|
| Mar 24, 2026 | $0.90 |
| Mar 25, 2026 | $0.88 |
| Mar 26, 2026 | $0.89 |
| Mar 27, 2026 | $0.89 |
| Mar 30, 2026 | $0.87 |
| Mar 31, 2026 | $1.18 |
| Apr 01, 2026 | $1.12 |
| Apr 02, 2026 | $0.84 |
| Apr 06, 2026 | $0.83 |
| 4 days before | -3.62% |
| 4 days after | -4.31% |
| On release day | 36.04% |
| Change in period | -7.78% |
| Release date | May 11, 2026 |
| Price on release | $1.03 |
| EPS estimate | -$0.0300 |
| EPS actual | - |
| Date | Price |
|---|---|
| May 05, 2026 | $0.98 |
| May 06, 2026 | $1.00 |
| May 07, 2026 | $0.98 |
| May 08, 2026 | $0.97 |
| May 11, 2026 | $1.03 |
| May 12, 2026 | $0.93 |
| May 13, 2026 | $0.91 |
| May 14, 2026 | $0.94 |
| May 15, 2026 | $0.97 |
| 4 days before | 5.13% |
| 4 days after | -5.37% |
| On release day | -9.76% |
| Change in period | -0.513% |
Oxbridge Re Holdings Earnings Call Transcript Summary of Q1 2026
Oxbridge reported Q1 2026 results reflecting continued focus on tokenized reinsurance and development of its SurancePlus real-world asset platform. Key financials: net premiums written were $555K (down from $595K a year ago), total revenue $623K (vs. $692K), and net income of $22K for the quarter (vs. a $139K loss prior year). Underwriting metrics showed a 0% loss ratio, an acquisition ratio of ~11%, but the combined ratio rose to 105% from 95.8%, driven by higher professional, investor-relations and subsidiary marketing costs. Cash and restricted cash increased to $8.19M, helped by premium deposits and a $1M short-term loan. Management highlighted strong performance of the company’s tokenized reinsurance contracts (balanced token tracking ~25% ahead of a 20% target; high-yield token on track for a 42% target) and ongoing ecosystem partnerships (Solana, Alphaledger, LayerZero) to expand interoperability across blockchain networks. The company is preparing T20 and T42 offerings for the 2026–27 cycle and is evaluating tokenization of additional cash-generating assets (including data-center and AI infrastructure revenue streams). Overall, Oxbridge emphasizes disciplined, data-driven underwriting, expansion of its tokenization platform, and measured scaling into new real-world asset categories while managing increased operating expenses.
Sign In
Buy OXBR